Enalare Therapeutics Inc
CAGE Code: 8G2D2
NCAGE Code: 8G2D2
Status: Active
Type: Commercial Supplier
Summary
Enalare Therapeutics Inc is an Active Commercial Supplier with the Cage Code 8G2D2.
Address
161 Hodge Rd
Princeton NJ 08540-3013
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Custom Mfg Services Inc Axiom Digital Inc Topps Electronic Services Inc Crossley Machine Co All Star Fire Protection Premier Concrete Inc Prairie Restorations Inc Alfa Systems Bracco Diagnostics Inc. Quarks Advantage Corp Book Sellers Inc Permevo Consulting Inc Premier Fastener Co Hamner Electronics Co Inc Anomaly Detection Systems Parsons Brinkerhoff Princeton Braillists Northington-Doviak Inc Advent Imaging Inc Key-Note Music Inc
Frequently Asked Questions (FAQ) for CAGE 8G2D2
- What is CAGE Code 8G2D2?
- 8G2D2 is the unique identifier used by NATO Organizations to reference the physical entity known as Enalare Therapeutics Inc located at 161 Hodge Rd, Princeton NJ 08540-3013, United States.
- Who is CAGE Code 8G2D2?
- 8G2D2 refers to Enalare Therapeutics Inc located at 161 Hodge Rd, Princeton NJ 08540-3013, United States.
- Where is CAGE Code 8G2D2 Located?
- CAGE Code 8G2D2 is located in Princeton, NJ, USA.
Contracting History for CAGE 8G2D2 Most Recent 25 Records
- 75A50122C00072
- Enalare Therapeutics: An Agnostic Respiratory Stimulant For Use As A Medical Countermeasure To Treat Respiratory Depression
- 22 Sep 2022
- Enalare Therapeutics: An Agnostic Respiratory Stimulant For Use As A Medical Countermeasure To Treat Respiratory Depression
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $5,955,427.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00072
- Correct Error From P00001
- 30 Sep 2023
- Correct Error From P00001
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $6,424,729.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00072
- Provide Supplemental Funding For Ena-001
- 20 Sep 2023
- Provide Supplemental Funding For Ena-001
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $6,424,729.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00044
- Eo14042 Enalare Therapeautics, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect) Ena-001
- 18 Nov 2021
- Eo14042 Enalare Therapeautics, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect) Ena-001
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,000.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00044
- Eo14042 Enalare Therapeautics, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect) Ena-001
- 21 Jul 2022
- Eo14042 Enalare Therapeautics, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect) Ena-001
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,000.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00044
- Enalare Therapeautics, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect) Ena-001
- 4 Aug 2021
- Enalare Therapeautics, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect) Ena-001
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,000.00
- Department Of Health And Human Services (Hhs)